Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004).
https://www.reportscorner.com/reports/21527/EpiCast-Report:-Asthma---Epidemiology-Forecast-to-2022/
3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
EpiCast Report: Asthma - Epidemiology Forecast to 2022
Summary
Asthma is one of the most common chronic diseases in the world,
with an estimated 300 million people suffering from the disease in
2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma
(GINA) report estimated that prevalence of asthma in the general
population varied widely in different countries around the world,
with proportions ranging between 1% in Albania and 18% in Wales
(Masoli et al., 2004; WHO, 2007). Asthma accounts for
approximately 250,000 deaths around the world annually, deaths
that otherwise could be easily prevented through appropriate
treatment (Masoli et al., 2004; WHO, 2007).
4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
GlobalData epidemiologists predict a substantial increase in the
number of lifetime prevalent cases of asthma in the 10 major
markets during the forecast period. GlobalData epidemiologists
forecast that there will be approximately 159.20 million lifetime
prevalent cases of asthma in the 10 major markets by 2022, with
an overall growth of 17.7% over the next decade. GlobalData
epidemiologists attribute the projected increase in the lifetime
prevalent cases of asthma across all the markets covered in this
analysis to changing population demographics in the respective
markets, except for the US and the UK, where this growth is also
attributed to trends in genetic determinants, social status,
environmental factors, and changes in policies related to disease
identification and recording (Simpson and Sheikh, 2010; Smith et
al., 2005).
Scope
5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
- The asthma EpiCast Report provides overview of the risk factors
and global trends for asthma in the 10 major markets (US, France,
Germany, Italy, Spain, UK, Japan, Australia, China, and India).
- In addition, the report includes a 10-year epidemiological
forecast of the lifetime prevalent cases of asthma segmented by
sex, age (in five-year increments beginning at 0 years and ending
at ages 85 years and older), and asthma severity in these 10
markets.
Reasons to buy
- Develop business strategies by understanding the trends
shaping and driving the global asthma market.
- Quantify patient populations in the global asthma market to
improve product development, pricing, and launch plans.
6. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
- Organize sales and marketing efforts by identifying the sex, age
groups, and disease severity groups that present the best
opportunities for asthma therapeutics in each of the markets
covered.
7. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.2.1 Family history of asthma is a strong predictor for asthma in children and adults 11
3.2.2 Puberty alters the risk for asthma in boys and girls 12
3.2.3 Maternal smoking during pregnancy increases the risk of childhood asthma by almost 70% 13
3.2.4 Allergens are well-known asthma triggers 14
3.2.5 Common workplace exposures account for up to 11% of asthma cases in adults 15
8. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
3.2.6 Urban living conditions, not race, increase the risk of asthma by almost 50% 16
3.2.7 Obesity almost triples the risk of developing asthma 17
3.2.8 Asthmatics are 90% more likely to develop GERD 18
3.2.9 85% of asthmatics have allergic rhinitis 19
3.2.10 Panic disorders are common in asthmatics and severely impact disease control 20
3.2.11 Thirty-nine percent of asthmatics are likely to develop depression 21
3.3 Global Trends 21
3.3.1 US 22
3.3.2 France 24
3.3.3 Germany 25
3.3.4 Italy 25
3.3.5 Spain 26
3.3.6 UK 27
3.3.7 Japan 28
3.3.8 Australia 29
9. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
3.3.9 China 29
3.3.10 India 30
3.4 Forecast Methodology 32
3.4.1 Sources Used 33
3.4.2 Forecast Assumptions and Methods 44
3.4.3 Sources Not Used 51
3.5 Epidemiology Forecast for Asthma (2012–2022) 51
3.5.1 Lifetime Prevalent Cases of Asthma 51
3.5.2 Age-Specific Lifetime Prevalent Cases of Asthma 53
3.5.3 Sex-Specific Lifetime Prevalent Cases of Asthma 55
3.5.4 Age-Standardized Lifetime Prevalence of Asthma 57
3.5.5 Distribution of Lifetime Prevalent Cases of Asthma by Severity 58
3.6 Discussion 61
3.6.1 Conclusions on Epidemiology Trends 61
3.6.2 Limitations of the Analysis 63
10. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
3.6.3 Strengths of the Analysis 64
4 Appendix 65
4.1 Bibliography 65
4.2 About the Authors 75
4.2.1 Epidemiologists 75
4.2.2 Reviewers 75
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 77
4.2.4 Global Head of Healthcare 77
4.3 About GlobalData 78
4.4 About EpiCast 78
4.5 Contact Us 79
4.6 Disclaimer 79
11. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/21527/EpiCast-Report:-Asthma---
Epidemiology-Forecast-to-2022/